View in EDS

Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer.

Saved in:
Bibliographic Details
Title: Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer.
Authors: Roudko V; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Del Valle DM; Precision Immunology Institute and Tisch Cancer Institute, Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Radkevich E; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kelly G; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Hui X; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Patel M; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Gonzalez-Kozlova E; Precision Immunology Institute and Tisch Cancer Institute, Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Tuballes K; Precision Immunology Institute and Tisch Cancer Institute, Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Streicher H; Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland, USA., Atale S; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada., Wang L; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada., CzinCzin B; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada., Kim-Schulze S; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Precision Immunology Institute and Tisch Cancer Institute, Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Wistuba II; Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Haymaker CL; Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Al-Atrash G; Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Manyam G; Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zhang J; Thoracic Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, UK., Thompson R; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Suarez-Farinas M; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Lheureux S; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada., Gnjatic S; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA sacha.gnjatic@mssm.edu.; Precision Immunology Institute and Tisch Cancer Institute, Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Feb 25; Vol. 13 (2). Date of Electronic Publication: 2025 Feb 25.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40010771
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Roudko+V%22">Roudko V</searchLink>; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Del+Valle+DM%22">Del Valle DM</searchLink>; Precision Immunology Institute and Tisch Cancer Institute, Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Radkevich+E%22">Radkevich E</searchLink>; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kelly+G%22">Kelly G</searchLink>; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Hui+X%22">Hui X</searchLink>; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Patel+M%22">Patel M</searchLink>; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Kozlova+E%22">Gonzalez-Kozlova E</searchLink>; Precision Immunology Institute and Tisch Cancer Institute, Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Tuballes+K%22">Tuballes K</searchLink>; Precision Immunology Institute and Tisch Cancer Institute, Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Streicher+H%22">Streicher H</searchLink>; Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Atale+S%22">Atale S</searchLink>; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22CzinCzin+B%22">CzinCzin B</searchLink>; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Kim-Schulze+S%22">Kim-Schulze S</searchLink>; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Precision Immunology Institute and Tisch Cancer Institute, Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Wistuba+II%22">Wistuba II</searchLink>; Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Haymaker+CL%22">Haymaker CL</searchLink>; Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Al-Atrash+G%22">Al-Atrash G</searchLink>; Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Manyam+G%22">Manyam G</searchLink>; Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Thoracic Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, UK.<br /><searchLink fieldCode="AU" term="%22Thompson+R%22">Thompson R</searchLink>; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Suarez-Farinas+M%22">Suarez-Farinas M</searchLink>; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lheureux+S%22">Lheureux S</searchLink>; Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Gnjatic+S%22">Gnjatic S</searchLink>; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA sacha.gnjatic@mssm.edu.; Precision Immunology Institute and Tisch Cancer Institute, Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2025 Feb 25; Vol. 13 (2). <i>Date of Electronic Publication: </i>2025 Feb 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40010771
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2024-010541
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Roudko V
      – PersonEntity:
          Name:
            NameFull: Del Valle DM
      – PersonEntity:
          Name:
            NameFull: Radkevich E
      – PersonEntity:
          Name:
            NameFull: Kelly G
      – PersonEntity:
          Name:
            NameFull: Hui X
      – PersonEntity:
          Name:
            NameFull: Patel M
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Kozlova E
      – PersonEntity:
          Name:
            NameFull: Tuballes K
      – PersonEntity:
          Name:
            NameFull: Streicher H
      – PersonEntity:
          Name:
            NameFull: Atale S
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: CzinCzin B
      – PersonEntity:
          Name:
            NameFull: Kim-Schulze S
      – PersonEntity:
          Name:
            NameFull: Wistuba II
      – PersonEntity:
          Name:
            NameFull: Haymaker CL
      – PersonEntity:
          Name:
            NameFull: Al-Atrash G
      – PersonEntity:
          Name:
            NameFull: Manyam G
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Thompson R
      – PersonEntity:
          Name:
            NameFull: Suarez-Farinas M
      – PersonEntity:
          Name:
            NameFull: Lheureux S
      – PersonEntity:
          Name:
            NameFull: Gnjatic S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 02
              Text: 2025 Feb 25
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1